Medtronic Bets On Untapped Venous Disease Opportunities
This article was originally published in Clinica
Executive Summary
While Medtronic has an established presence in many cardio- and peripheral vascular market segments, the medtech giant is a relative newcomer to the venous disease space, having gained access to this market through Covidien’s legacy endovenous portfolio.